tiprankstipranks
Trending News
More News >
Geron Corp (GERN)
NASDAQ:GERN
US Market

Geron (GERN) Stock Forecast & Price Target

Compare
2,421 Followers
See the Price Targets and Ratings of:

GERN Analyst Ratings

Strong Buy
8Ratings
Strong Buy
6 Buy
2 Hold
0 Sell
Based on 8 analysts giving stock ratings to
Geron
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GERN Stock 12 Month Forecast

Average Price Target

$4.08
▲(155.00%Upside)
Based on 8 Wall Street analysts offering 12 month price targets for Geron in the last 3 months. The average price target is $4.08 with a high forecast of $6.00 and a low forecast of $1.50. The average price target represents a 155.00% change from the last price of $1.60.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","7":"$7","1.75":"$1.75","3.5":"$3.5","5.25":"$5.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$6.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.08,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$4.08</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$1.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1.75,3.5,5.25,7],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.43,1.7815384615384615,2.1330769230769233,2.4846153846153847,2.836153846153846,3.187692307692308,3.5392307692307696,3.890769230769231,4.242307692307692,4.593846153846154,4.945384615384616,5.296923076923077,5.648461538461539,{"y":6,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.43,1.6338461538461537,1.8376923076923077,2.0415384615384617,2.2453846153846153,2.4492307692307693,2.653076923076923,2.856923076923077,3.060769230769231,3.264615384615385,3.468461538461539,3.672307692307693,3.876153846153846,{"y":4.08,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.43,1.4353846153846153,1.4407692307692308,1.4461538461538461,1.4515384615384614,1.456923076923077,1.4623076923076923,1.4676923076923076,1.473076923076923,1.4784615384615385,1.4838461538461538,1.4892307692307691,1.4946153846153847,{"y":1.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.08,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.55,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.34,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.78,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.75,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.41,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.11,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.04,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.54,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.87,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.76,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.48,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.43,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$6.00Average Price Target$4.08Lowest Price Target$1.50
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on GERN
TipRanks AITipRanks
Not Ranked
TipRanks
$1.5
Hold
-6.25%
Downside
Reiterated
06/04/25
Geron's overall stock score is driven by financial challenges, with persistent losses and negative cash flows being significant concerns. Technical indicators provide mixed signals, while strategic initiatives in the earnings call offer potential for future improvements. However, the current valuation reflects the difficulties in achieving profitability.
Leerink Partners Analyst forecast on GERN
Faisal KhurshidLeerink Partners
Leerink Partners
Buy
Reiterated
06/01/25
Analysts Offer Insights on Healthcare Companies: Sanofi (NASDAQ: SNY), NovoCure (NASDAQ: NVCR) and Geron (NASDAQ: GERN)
TD Cowen
$4
Buy
150.00%
Upside
Reiterated
05/12/25
TD Cowen Sticks to Their Buy Rating for Geron (GERN)
Scotiabank Analyst forecast on GERN
Greg HarrisonScotiabank
Scotiabank
$4$1.5
Hold
-6.25%
Downside
Downgraded
05/08/25
Geron downgraded to Sector Perform from Outperform at ScotiabankGeron downgraded to Sector Perform from Outperform at Scotiabank
Wedbush
$7$6
Buy
275.00%
Upside
Reiterated
05/08/25
Geron (GERN) Gets a Buy from Wedbush
Barclays Analyst forecast on GERN
Peter LawsonBarclays
Barclays
$4
Buy
150.00%
Upside
Reiterated
05/08/25
Barclays Reaffirms Their Buy Rating on Geron (GERN)
H.C. Wainwright Analyst forecast on GERN
Emily BodnarH.C. Wainwright
H.C. Wainwright
Hold
Reiterated
05/07/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Geron (NASDAQ: GERN) and Immunocore Holdings (NASDAQ: IMCR)
Needham Analyst forecast on GERN
Gil BlumNeedham
Needham
$5
Buy
212.50%
Upside
Reiterated
05/07/25
Positive Growth Prospects for Geron Amid Strategic Expansion and Strong Financial Position
Stifel Nicolaus Analyst forecast on GERN
Stephen WilleyStifel Nicolaus
Stifel Nicolaus
$4
Buy
150.00%
Upside
Reiterated
03/12/25
Stifel Nicolaus Sticks to Its Buy Rating for Geron (GERN)
B.Riley Financial Analyst forecast on GERN
Kalpit PatelB.Riley Financial
B.Riley Financial
$3.5$2
Hold
25.00%
Upside
Downgraded
02/26/25
Geron downgraded to Neutral from Buy at B. RileyGeron downgraded to Neutral from Buy at B. Riley
Cantor Fitzgerald Analyst forecast on GERN
Carter GouldCantor Fitzgerald
Cantor Fitzgerald
$9
Buy
462.50%
Upside
Assigned
11/08/24
Barclays Sticks to Its Buy Rating for Geron (GERN)
Goldman Sachs Analyst forecast on GERN
Corinne JohnsonGoldman Sachs
Goldman Sachs
$6
Buy
275.00%
Upside
Reiterated
10/03/24
Buy Rating on Geron Corp: Rytelo's Reimbursement and Market Adoption Promise Peak Sales
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on GERN
TipRanks AITipRanks
Not Ranked
TipRanks
$1.5
Hold
-6.25%
Downside
Reiterated
06/04/25
Geron's overall stock score is driven by financial challenges, with persistent losses and negative cash flows being significant concerns. Technical indicators provide mixed signals, while strategic initiatives in the earnings call offer potential for future improvements. However, the current valuation reflects the difficulties in achieving profitability.
Leerink Partners Analyst forecast on GERN
Faisal KhurshidLeerink Partners
Leerink Partners
Buy
Reiterated
06/01/25
Analysts Offer Insights on Healthcare Companies: Sanofi (NASDAQ: SNY), NovoCure (NASDAQ: NVCR) and Geron (NASDAQ: GERN)
TD Cowen
$4
Buy
150.00%
Upside
Reiterated
05/12/25
TD Cowen Sticks to Their Buy Rating for Geron (GERN)
Scotiabank Analyst forecast on GERN
Greg HarrisonScotiabank
Scotiabank
$4$1.5
Hold
-6.25%
Downside
Downgraded
05/08/25
Geron downgraded to Sector Perform from Outperform at ScotiabankGeron downgraded to Sector Perform from Outperform at Scotiabank
Wedbush
$7$6
Buy
275.00%
Upside
Reiterated
05/08/25
Geron (GERN) Gets a Buy from Wedbush
Barclays Analyst forecast on GERN
Peter LawsonBarclays
Barclays
$4
Buy
150.00%
Upside
Reiterated
05/08/25
Barclays Reaffirms Their Buy Rating on Geron (GERN)
H.C. Wainwright Analyst forecast on GERN
Emily BodnarH.C. Wainwright
H.C. Wainwright
Hold
Reiterated
05/07/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Geron (NASDAQ: GERN) and Immunocore Holdings (NASDAQ: IMCR)
Needham Analyst forecast on GERN
Gil BlumNeedham
Needham
$5
Buy
212.50%
Upside
Reiterated
05/07/25
Positive Growth Prospects for Geron Amid Strategic Expansion and Strong Financial Position
Stifel Nicolaus Analyst forecast on GERN
Stephen WilleyStifel Nicolaus
Stifel Nicolaus
$4
Buy
150.00%
Upside
Reiterated
03/12/25
Stifel Nicolaus Sticks to Its Buy Rating for Geron (GERN)
B.Riley Financial Analyst forecast on GERN
Kalpit PatelB.Riley Financial
B.Riley Financial
$3.5$2
Hold
25.00%
Upside
Downgraded
02/26/25
Geron downgraded to Neutral from Buy at B. RileyGeron downgraded to Neutral from Buy at B. Riley
Cantor Fitzgerald Analyst forecast on GERN
Carter GouldCantor Fitzgerald
Cantor Fitzgerald
$9
Buy
462.50%
Upside
Assigned
11/08/24
Barclays Sticks to Its Buy Rating for Geron (GERN)
Goldman Sachs Analyst forecast on GERN
Corinne JohnsonGoldman Sachs
Goldman Sachs
$6
Buy
275.00%
Upside
Reiterated
10/03/24
Buy Rating on Geron Corp: Rytelo's Reimbursement and Market Adoption Promise Peak Sales
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Geron

1 Month
xxx
Success Rate
6/12 ratings generated profit
50%
Average Return
+8.43%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +8.43% per trade.
3 Months
xxx
Success Rate
14/26 ratings generated profit
54%
Average Return
+5.20%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 53.85% of your transactions generating a profit, with an average return of +5.20% per trade.
1 Year
Gil BlumNeedham
Success Rate
11/26 ratings generated profit
42%
Average Return
+5.71%
reiterated a buy rating last month
Copying Gil Blum's trades and holding each position for 1 Year would result in 42.31% of your transactions generating a profit, with an average return of +5.71% per trade.
2 Years
xxx
Success Rate
9/26 ratings generated profit
35%
Average Return
-1.32%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 34.62% of your transactions generating a profit, with an average return of -1.32% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GERN Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
19
20
16
14
13
Buy
5
4
4
1
0
Hold
0
2
3
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
24
26
23
18
16
In the current month, GERN has received 13 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. GERN average Analyst price target in the past 3 months is 4.08.
Each month's total comprises the sum of three months' worth of ratings.

GERN Financial Forecast

GERN Earnings Forecast

Next quarter’s earnings estimate for GERN is -$0.03 with a range of -$0.04 to -$0.01. The previous quarter’s EPS was -$0.03. GERN beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year GERN has Outperformed its overall industry.
Next quarter’s earnings estimate for GERN is -$0.03 with a range of -$0.04 to -$0.01. The previous quarter’s EPS was -$0.03. GERN beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year GERN has Outperformed its overall industry.

GERN Sales Forecast

Next quarter’s sales forecast for GERN is $47.81M with a range of $42.02M to $54.56M. The previous quarter’s sales results were $39.60M. GERN beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.56% of the time in the same period. In the last calendar year GERN has Outperformed its overall industry.
Next quarter’s sales forecast for GERN is $47.81M with a range of $42.02M to $54.56M. The previous quarter’s sales results were $39.60M. GERN beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.56% of the time in the same period. In the last calendar year GERN has Outperformed its overall industry.

GERN Stock Forecast FAQ

What is GERN’s average 12-month price target, according to analysts?
Based on analyst ratings, Geron Corp’s 12-month average price target is 4.08.
    What is GERN’s upside potential, based on the analysts’ average price target?
    Geron Corp has 155.00% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is GERN a Buy, Sell or Hold?
          Geron Corp has a consensus rating of Strong Buy which is based on 6 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Geron Corp’s price target?
            The average price target for Geron Corp is 4.08. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $6.00 ,the lowest forecast is $1.50. The average price target represents 155.00% Increase from the current price of $1.6.
              What do analysts say about Geron Corp?
              Geron Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
                How can I buy shares of GERN?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis